In Vivo Study on the Effect Docetaxel on Apoptosis and Proliferation Inhibition of Murine-phenotypic Angiosarcoma (ISOS-1) Cell

姜日花,李玉林,张丽红,增澤幹男
DOI: https://doi.org/10.3760/j.issn:0412-4030.2004.07.003
2004-01-01
Chinese Journal of Dermatology
Abstract:Objective To study the effects of docetaxel on murine-phenotypic angiosarcoma cell(ISOS-1)apoptosis and proliferation in vivo. Methods Animal model was established for murine-phenotypic angiosarcoma, and twenty model mice were divided into four groups: mice treated with 5 mg/kg, 10 mg/kg, 20 mg/kg of docetaxel and a control group. Each group included five mice. Docetaxel was administrated by i.v. injection once a week. The tumor size was monitored, the ultrastructural changes were observed by electron microscopy, and the apoptosis rate was detected with terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling(TUNEL). Results The inhibitory rates of tumor size were 71%, 77% and 79% in the 5 mg/kg, 10 mg/kg and 20 mg/kg, respectively, which showed a significant effect on the proliferative inhibition (P 0.01), compared with the control group. The early apoptosis could be observed in the ultrastructural changes in three docetaxel groups. The apoptotic rate of ISOS-1 cell was higher than that in the control group (P 0.01). Conclusions Docetaxel can induce murine-phenotypic angiosarcoma cell (ISOS-1) apoptosis and inhibit the tumor growth in mice.
What problem does this paper attempt to address?